| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/CVI.00636-13 |
| P8608 | Fatcat ID | release_4klm2ozkjzeu5k3x4m3npby3f4 |
| P932 | PMC publication ID | 3957659 |
| P698 | PubMed publication ID | 24403523 |
| P50 | author | Dong-Hun Lee | Q40949005 |
| Chang-Seon Song | Q87144562 | ||
| Sungsu Youk | Q90076781 | ||
| Jung-Hoon Kwon | Q105612145 | ||
| P2093 | author name string | Sang-Moo Kang | |
| In-Soo Choi | |||
| Joong-Bok Lee | |||
| Seung-Yong Park | |||
| Jin-Yong Noh | |||
| Seong-Su Yuk | |||
| Erdene-Ochir Tseren-Ochir | |||
| Jae-Keun Park | |||
| Byoung-Yoon Kim | |||
| Soo-Won Choi | |||
| P2860 | cites work | A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | Q24631774 |
| Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy | Q30418285 | ||
| Virus-like particles as universal influenza vaccines | Q30421558 | ||
| Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge | Q33386427 | ||
| Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins | Q33612439 | ||
| Assembly and biological and immunological properties of Newcastle disease virus-like particles | Q33826688 | ||
| Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus | Q34019891 | ||
| Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens | Q35077454 | ||
| Requirements for the assembly and release of Newcastle disease virus-like particles | Q35139627 | ||
| Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice | Q35188476 | ||
| Virus-like particles as immunogens | Q35295832 | ||
| Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples | Q35551905 | ||
| Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. | Q36668679 | ||
| Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes | Q37279007 | ||
| The coming of age of virus-like particle vaccines | Q37309265 | ||
| Virus-like particles in vaccine development. | Q37798008 | ||
| Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development | Q38059059 | ||
| Insect cells as a production platform of complex virus-like particles | Q38081976 | ||
| Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions | Q38423822 | ||
| MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination | Q38725392 | ||
| Virus-like particle vaccine protects against H3N2 canine influenza virus in dog. | Q39204975 | ||
| Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens | Q39780308 | ||
| H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals | Q41378949 | ||
| Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein | Q44203586 | ||
| Newcastle disease virus F glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live-virus challenge | Q45391629 | ||
| P433 | issue | 3 | |
| P921 | main subject | Newcastle disease virus | Q327082 |
| Newcastle disease | Q11903425 | ||
| P304 | page(s) | 360-365 | |
| P577 | publication date | 2014-01-08 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals | |
| P478 | volume | 21 |
| Q91750540 | A Novel Cre Recombinase-Mediated In Vivo Minicircle DNA (CRIM) Vaccine Provides Partial Protection against Newcastle Disease Virus |
| Q90461135 | A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding |
| Q36132477 | Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA). |
| Q63246352 | Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus |
| Q45324355 | Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein. |
| Q58800131 | Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives |
| Q38843665 | Immunogenicity and protective efficacy of virus-like particles and recombinant fiber proteins in broiler-breeder vaccination against fowl adenovirus (FAdV)-8b |
| Q38647070 | Recent outbreaks of highly pathogenic avian influenza viruses in South Korea. |
| Q64125031 | Recombinant duck enteritis viruses expressing the Newcastle disease virus (NDV) F gene protects chickens from lethal NDV challenge |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q38603912 | The application of virus-like particles as vaccines and biological vehicles |
Search more.